Afternoon comments on Hong Kong stocks: Hang Seng Index rose by 1.72%, Hang Seng Technology Index rose by 2.55%, Hong Kong stocks closed at noon, Hang Seng Index rose by 1.72% and Hang Seng Technology Index rose by 2.55%. Chinese brokerage stocks and consumer stocks were among the top gainers, with China Merchants Securities, Mengniu Dairy and Tongcheng Travel up over 7% and over 5% respectively.Korean media: South Korea's ruling party has added another person to support the impeachment of Yin Xiyue, and the number of members in favor has now increased to six. According to the latest news in Yonhap News Agency, Zhongwu Qin, a member of parliament of South Korea's ruling National Power Party, said on the 12th that he would vote for the impeachment of the president on the 14th. Yonhap News Agency said that so far, the number of members of the ruling party who have publicly expressed their support for the impeachment of President Yin Xiyue has increased to six.The tenth batch of centralized procurement of drugs organized by the state will be opened in Shanghai today (12th), and the bid will be selected. It is understood that this collection involves a total of 62 drugs and 263 product specifications, which is the highest in all previous collections. Covers a variety of therapeutic fields such as hypertension, diabetes, tumor, cardiovascular and cerebrovascular diseases, infection, mental illness, and electrolyte supplementation. (CCTV Finance)
The main fuel contract rose by 4.00% in the day and is now reported at 3188.00 yuan/ton.Sources: The Bank of Japan tends to keep interest rates unchanged next week. Five sources familiar with the Bank of Japan's thinking said that the Bank of Japan tends to keep interest rates unchanged next week because policymakers tend to spend more time examining overseas risks and clues about salary increase next year. Any similar decision will increase the possibility that the Bank of Japan will raise interest rates at its meeting in January or March next year, when there will be more information about the wage increase next year. The source also said that there was no consensus within the Bank of Japan on the final decision, and some people in the Committee still believed that Japan had met the conditions for raising interest rates in December. This decision will depend on each member's belief in the possibility of achieving wage-driven sustained price increases in Japan. If upcoming events, such as next week's meeting of the Federal Reserve, trigger another sharp fall in the yen, thus intensifying inflationary pressure, the Bank of Japan may also agree to raise interest rates. But overall, many BoJ policymakers seem to be in no hurry to pull the trigger.Shenzhen Component Index opened at 10942.05 points in the afternoon, up 0.86%. The GEM index opened at 2,297.69 points in the afternoon, up 1.60%. The small and medium-sized board opened at 11,810.25 points in the afternoon, an increase of 0.61%; The Shanghai Composite Index opened at 3,455.06 points in the afternoon, up 0.66%. The Shanghai and Shenzhen 300 Index opened at 4023.60 points in the afternoon, up 0.87%.
Iflytek and other robot technology companies have a registered capital of 30 million yuan. According to Tianyancha App, Anhui Lingdong General Robot Technology Co., Ltd. was recently established with Hu Guoping as the legal representative and a registered capital of 30 million yuan. Its business scope includes industrial robot manufacturing, industrial robot sales, intelligent robot research and development, electrical equipment sales, computer software and hardware and auxiliary equipment retail, information system integration services, intelligent robot sales, mechanical equipment leasing, etc. According to shareholder information, the company is jointly held by Anhui Xunfei Yunchuang Technology Co., Ltd., a subsidiary of Iflytek (002230), Anhui Yanzhi Technology Co., Ltd. and Anhui Lingji Wanwu Technology Partnership (Limited Partnership).Yamato: Raising the target price of IWC to HK$ 20 has a more positive view on next year's revenue growth. Yamato published a report that under the strong demand from Malaysia, the bank has a more positive view on IWC's revenue growth next year. In addition, the bank believes that the external financing of operating GDSI, a data center outside the mainland, will release shareholder value. However, as GDSI will be separated from IWC's consolidated statements in the fourth quarter of this year, the bank believes that IWC's short-term re-evaluation will still mainly depend on its mainland business performance, so it still maintains a wait-and-see attitude. The bank maintained its "hold" rating on IWC, and its target price was raised from HK$ 8.6 to HK$ 20. Considering the increase in capital expenditure of IWC from 2025 to 2026, the bank raised its revenue forecast for this year and next by 5% to 24%, mainly due to the strong demand in the international market driven by short video platforms. In addition, in view of the fact that the company raised its capital expenditure guideline from 6.5 billion yuan to 11 billion yuan this year, the bank raised its capital expenditure forecast from 6.7 billion yuan to 11 billion yuan in 2024 and from 3.5 billion yuan to 10.5 billion yuan in 2025. In addition, the bank will raise the adjusted EBITDA forecast of IWC this year and next by 4% to 13% to consider the EBITDA contribution of its overseas business; It is estimated that the total revenue will increase by 15% this year (10% compared with the previous forecast) and 33% next year (15% compared with the previous forecast). The adjusted EBITDA is expected to increase by 11% and 25% this year and next (8% and 15% compared with the previous forecast).Renhe Pharmaceutical invested in Jiangxi to establish a health industry company. According to the enterprise search APP, Jiangxi Renhe Jiuniuai Health Industry Co., Ltd. was recently established, with Xin Li as the legal representative and a registered capital of 1 million yuan. Its business scope includes: food Internet sales, health food production, health care services (non-medical), health consulting services, sales of first-class medical devices, sales of agricultural and sideline products, etc. Enterprise survey shows that the company is jointly held by Renhe Pharmaceutical and Xin Li.
Strategy guide
12-14
Strategy guide
Strategy guide